Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02643966 · ClinicalTrials.gov registry record · NA
Assessment of Periodic Screening of Women With Denser Breast Using WBUS and DBT
A NA study, sponsored by Wendie Berg.
- Completed
- Registry status
- NA
- Development phase
- 6,266
- Enrollment target
NCT02643966 is a NA study that has completed, run by Wendie Berg. The registered enrollment target is 6,266 participants.
The verdict
NCT02643966, a NA study, has completed, sponsored by Wendie Berg.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,266 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the role of technologist-performed whole breast ultrasound for detecting breast cancer in the screening population of women with dense breasts.
Interventions
- DEVICE Whole breast ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,266 participants |
| Start Date | 2015-12 |
| Est. Completion | 2022-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02643966
The ClinicalTrials.gov registry entry for NCT02643966 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6,266 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wendie Berg, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Whole breast ultrasound is the first listed.
NCT02643966 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02643966 about?
NCT02643966 is a clinical study titled "Assessment of Periodic Screening of Women With Denser Breast Using WBUS and DBT". The purpose of this study is to evaluate the role of technologist-performed whole breast ultrasound for detecting breast cancer in the screening population of women with dense breasts.
What is the current status of trial NCT02643966?
This trial is currently completed. It is a NA study. The enrollment target is 6,266 participants. The study started on 2015-12. Estimated completion is 2022-05.
What interventions are being tested in trial NCT02643966?
The interventions under investigation include: Whole breast ultrasound (DEVICE).
Who is sponsoring clinical trial NCT02643966?
This trial is sponsored by Wendie Berg, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.